Advertisement
Canada markets closed
  • S&P/TSX

    22,059.03
    -184.99 (-0.83%)
     
  • S&P 500

    5,567.19
    +30.17 (+0.54%)
     
  • DOW

    39,375.87
    +67.87 (+0.17%)
     
  • CAD/USD

    0.7332
    -0.0015 (-0.20%)
     
  • CRUDE OIL

    83.33
    -0.55 (-0.66%)
     
  • Bitcoin CAD

    77,073.39
    -2,582.16 (-3.24%)
     
  • CMC Crypto 200

    1,172.13
    -36.56 (-3.03%)
     
  • GOLD FUTURES

    2,399.90
    +30.50 (+1.29%)
     
  • RUSSELL 2000

    2,026.73
    -9.90 (-0.49%)
     
  • 10-Yr Bond

    4.2720
    -0.0830 (-1.91%)
     
  • NASDAQ

    18,352.76
    +164.46 (+0.90%)
     
  • VOLATILITY

    12.48
    +0.22 (+1.79%)
     
  • FTSE

    8,203.93
    -37.33 (-0.45%)
     
  • NIKKEI 225

    40,912.37
    -1.28 (-0.00%)
     
  • CAD/EUR

    0.6762
    -0.0030 (-0.44%)
     

Artisan Investments raises stake in Philips to 10%, regulatory filing shows

Philips Healthcare headquarters is seen in Best

AMSTERDAM (Reuters) - U.S. asset management firm Artisan Investments has raised its stake in Philips to 10%, sending the healthcare technology group's shares rising on Wednesday, a week after the Dutch company's biggest shareholder also increased its holding.

At 1045 GMT, Philips shares were up 1.66% at 23.90 euros, outperforming the Dutch stock market blue-chip AEX (+1.05%) as well as the Stoxx Europe 600 healthcare index (-0.1%).

After raising its stake, Artisan Investments now owns 94.13 million shares in Philips, or about 10% of the company, according to a regulatory filing published earlier.

"Artisan has owned more than 9% in Philips for quite some time and has recently increased their stake to 10% after (our) Q1 results. We see this as a signal of trust in our strategy and plan," a Philips spokesperson told Reuters.

ADVERTISEMENT

Artisan Investments is now Philips' second-largest shareholder behind Exor, the investment arm of Italy's Agnelli family, which increased its stake to 17.51% last week.

Philips reported a better-than-expected first-quarter profit on April 29, with its adjusted earnings before interest, taxes and amortisation (EBITA) jumping 8% to 388 million euros ($417.22 million).

The company also announced a smaller-than-expected settlement on the same day to resolve claims over recalled breathing devices in the U.S.

($1 = 0.9300 euros)

(Reporting by Toby Sterling and Benoit Van Overstraeten; Editing by Louise Heavens and Anil D'Silva)